Interferon-α for TP53 Myeloid Malignancy Post Allo-HSCT

Clinical trial NCT06130579 · RECRUITING

Trial details

NCT number: NCT06130579
Sponsor: Peking University People's Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Myeloid Leukemia Myelodysplastic Syndromes

Start date: 2024-01-01
Primary completion: 2025-12-31
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.